We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
KRYS icon
26
Krystal Biotech
KRYS
$9.97B
$9.97B $336.67 0%
KYMR icon
27
Kymera Therapeutics
KYMR
$9.67B
$9.67B $116.33 2.81%
CYTK icon
28
Cytokinetics
CYTK
$9.65B
$9.65B $69.39 0.12%
TWST icon
29
Twist Bioscience
TWST
$9.49B
$9.49B $143.07 3.6%
ARWR icon
30
Arrowhead Research
ARWR
$9.29B
$9.29B $65.79 6.91%
PTGX icon
31
Protagonist Therapeutics
PTGX
$9.24B
$9.24B $142.84 0.39%
ABVX
32
Abivax
ABVX
$8.92B
$8.92B $102.23 4.15%
PCVX icon
33
Vaxcyte
PCVX
$8.75B
$8.75B $58.77 0.74%
PRAX icon
34
Praxis Precision Medicines
PRAX
$8.63B
$8.63B $308.99 1.25%
TGTX icon
35
TG Therapeutics
TGTX
$8.55B
$8.55B $55.85 5.3%
IBRX icon
36
ImmunityBio
IBRX
$8.38B
$8.38B $7.91 2.83%
SYRE icon
37
Spyre Therapeutics
SYRE
$8.04B
$8.04B $91.17 0.24%
CAI
38
Caris Life Sciences
CAI
$7.97B
$7.97B $28.21 1.02%
IMVT icon
39
Immunovant
IMVT
$7.51B
$7.51B $36.38 0.74%
IONS icon
40
Ionis Pharmaceuticals
IONS
$7.45B
$7.45B $44.84 5.1%
BLTE
41
Belite Bio
BLTE
$6.81B
$6.81B $169.21 0.14%
RYTM icon
42
Rhythm Pharmaceuticals
RYTM
$6.75B
$6.75B $98.01 1.28%
CGON icon
43
CG Oncology
CGON
$6.57B
$6.57B $74.12 2.16%
MIRM icon
44
Mirum Pharmaceuticals
MIRM
$6.32B
$6.32B $97.37 3.7%
ORKA
45
Oruka Therapeutics
ORKA
$6.19B
$6.19B $93.55 1.46%
SRRK icon
46
Scholar Rock
SRRK
$6.01B
$6.01B $49.37 1.26%
TVTX icon
47
Travere Therapeutics
TVTX
$5.98B
$5.98B $63.48 1.55%
DNTH icon
48
Dianthus Therapeutics
DNTH
$5.73B
$5.73B $102.49 2.18%
COGT icon
49
Cogent Biosciences
COGT
$5.65B
$5.65B $32.54 0.61%
PTCT icon
50
PTC Therapeutics
PTCT
$5.64B
$5.64B $67.59 2.96%
1
2
3 4 5

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.